Characteristics of treatment naive chronic hepatitis B in Bangladesh: Younger populations are more affected; HBeAg-negatives are more advanced

Saudi Journal of Gastroenterology

Volumn 14, Issue 1, 2008, Pages 15-19

  Alam, Shahinul ^a   Ahmad, Nooruddin ^a   Mustafa, Golam ^a   Alam, Khorshed ^a   Khan, Mobin ^a  

^a BANGABANDHU SHEIKH MUJIB MEDICAL UNIVERSITY   (Bangladesh)

Author keywords

Age; Bangladesh; Chronic hepatitis B

Indexed keywords

EID: 38149122369     PISSN: 13193767     EISSN: None     Source Type: Journal    
DOI: 10.4103/1319-3767.37796     Document Type: Article

References (45)

1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment and current and emerging prevention and control measures. J Viral Hepat 2004;11:97-107.
2. Bosch EX, Ribes J, Cleries R, Diaz M. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2005;9:191-211.
3. McMahon BJ, Hepatocellular carcinoma and viral hepatitis. In Wilson RA editor. Viral, hepatitis. Marcel Dekker: New York; 1997. p. 315-30.
4. Fat tovich G, Brollo L, Giustina G, Noventa E Ponds so R Albertia A et al. Natural history and prognostic factors for chronic hepatitis type B. Gut 1991;32:294-8.
5. Liaw YE Tai DI, Chu CM, Chen TJ, The development of cirrhosis in patients with, chronic type Bhepatitis: Aprospective study. Hepatology 1988;8:493-6.
6. Yu MW, Hsu FC, Sheen IS, Chu CM, Lin DY Chen CI, et al. Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. An J Epidemiol 1997;145:1039-47.
7. Weissberg JI, Andres s LL, Smith CL, Weick S, Nichols JF, Garcia G, et al. Survival in chronic hepatitis B: An analysis of 379 patients. Ann Intern Med 1984;101:613-6.
8. Islam MN, Islam KM, Islam N. Hepatitis B virus in Dhaka, Bangladesh. Bangladesh Med Res Counc Bull 1984;10:1-6.
9. Khan M, Ahmad N. Seroepidemiology of HBVand HCVin Bangladesh. Int Hepatol Commun 1996;5:27-9.
10. Hoofnagle JH, Dusheiko GM, Seeff LB, Jones EA Waggoner JG, Bales ZB. Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Ann Intern Med 1981;94:744-8.
11. Realdi. G, Aberti. A Rugge M, Bortolotti E Rigoli AM Tremolada E et al. Seroconversion from hepatitis Be antigen to anti-HBe in chronic hepatitis B virus infection. Gastroenterology 1980;79:195-9.
12. Funk MI, Rosenberg DM, Lok AS. World-wide epidemiology of HBe Agnegative chronic hepatitis Band associated precore and core promoter variants. J Viral Hepat 2002;9:52-61.
13. Brunetto MR, Oliveri F, Coco B, Leandro G, Colombatto E Gorin JM, et al. Outcome of anti-HBe positive chronic hepatitis Bin alpha-interferon treated and untreated patients: Along term cohort study. J Hepatol 2002;36:263-70.
14. Hadziyannis SJ. HBeAg-negative chronic hepatitis B: From clinical recognition to pathogenesis and treatment. Viral Hepat Rev 1995;1:7-15.
15. Hadziyannis SJ, Vassilopoulos D. HBeAg-negative chronic hepatitis H Hepatology 2001;34:617-24.
16. Lampertico P, Del Ninoo F, Manzin A Donato MF, Rumi MG, Lunghi G, et ai. Arandomized controlled trial of a 24-month course of interferon alpha 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis Be antigen in serum. Hepatology 1997;26: 162.1-5.
17. Papatheodoridis GV, Manesis E, Hadziyannis SJ. The long-term outcome of interferon-treated and untreated patients with HBeAg-negative chronic hepatitis B J Hepatol 2001;34:306-13.
18. Chan HL Leung NW, Hussein M Wong ML, Lok AS. Hepatitis Be antigennegative chronic hepatitis B in Hong Kong. Hepatology 2000;31:763-8.
19. Yoo BC, Park JW, Kim HJ, Lee DH Cha YJ, Park SM Precore and core promoter mutation of hepatitis B virus and hepatitis B virus antigennegative chronic hepatitis B in Korea. J Hepatol 2003;38:98-103.
20. Khodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
21. Zarski JR Marcellin P, Leroy V, Trepo Q Samuel D, Ganne N, et al. Characteristics of patients with chronic hepatitis B in France: Predominant frequency of HBe Ag-negative cases. J Hepatol 2006;45:355-60.
22. Iiaw YF Results of lamivudine trial in Asia. J Hepatol 2003;39:S111.-5.
23. Lok AS, Lai CL, Wu PC, Leung EK, Lam TS. Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection. Gastroenterology 1987;92:1839-43.
24. Sànchez-Tapias JM, Vilar JH, Costa J, Bruguera M, Ballesta AM, Ròdes J. Natural, history of chronic persistent hepatitis B. Relationship between hepatitis B virus replication and the course of the disease. J Hepatol 1985;1:15-27.
25. Fattovich G, Rugge M, Brollo I, Pontisso P, Noventa F, Guido M, et al. Clinical, virologie and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B. Hepatology 1986;6:167-72.
26. Moreno-Otero R Garcia-Monzòn C, Garcia-Sànchez A Buey LG, Pajares JM Di Bisceglie AM. Development of cirrhosis after chronic type B hepatitis: Aclinicopathologic and follow-up study of 46 HBe Ag-positive asymptomatic patients. An J Gastroenterol 1991;86:560-4.
27. Di Marco Y Lo Iacono O, Cammà C, Vaccaro A Giunta M Martorana G, et al. The .long-term course of chronic hepatitis B. Hepatology 1999;30:257-64.
28. Lin SM Sheen IS, Chien RN, Chu CM, Liaw Yl? Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection. Hepatology 1999;29:971-5.
29. Yien ME Hui CK, Cheng CC, Wu CH, Lai YP, Lai CL Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: the effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications. Hepatology 2001;34:139-45.
30. Mangia A Chung YH, Hoofnagle JH, Hrken-Meyer L, Mushahwar I, Di Bisceglie AM Pathogenesis of chronic liver disease in patients with chronic hepatitis B virus infection without serum HBeAg. Dig Dis Sci 1996;41:2447-52.
31. Tassopoulos NC, Volpes R, Pastore G-, Heathcote J, Buti M, Goldin RD, et al. Efficacy of lainivudine in patients with hepatitis B e antigennegative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B Hepatology 1999;29:889-96.
32. Chu CJ, Keeffe EB, Lian SH Perrillo RR Min AD, Soldevila-Pico C, et al. Prevalence HBV precore/core promoter variants United States. Hepatology 2003;38:619-28.
33. Knoll A Rohihofer A Kocharowski B, Wurm EM, Jily W Prevalence of precore mutation in anti HBe-positive hepatitis B virus carrier in Germany. J Med Virol 1999;59:14-8.
34. Zarski JR Marcellin R Cohard M, Lutz JM Bouche Q Rais A Comparison of anti-HBe-positive and HBeAg-positive chronic hepatitis B in France. J Hepatol 1994;20:636-40.
35. diu CJ, Hussain M, Lok AS. Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection. Hepatology 2002;36:1408-15.
36. Mommega-Marin H, Mondon E, Bium MR, Rousseau E Serum HBV DNA as a marker of efficacy during therapy for chronic HBVinfection: Analysis and review of the literature. Hepatology 2003;37:1309-19.
37. Lindh M, Horal P, Dhillon AR Norkrans G. Hepatitis B virus DNAlevels, precore mutations, genotypes and histological activity in chronic hepatitis B. J Viral Hepat 2000;7:258-67.
38. Zavaglia C, Mondazzi L Maggi G, Iamoni G, Gelosa I; Bellati G, et al. Ae alanine aminotransferase, hepatitis B virus DNAor IgM antibody to hepatitis Bcore antigen serum levels predictors of histological grading in chronic hepatitis B? liver 1997;17:83-7.
39. Yuen MF, Irene OL, Fan ST, Yian HJ, Wong DK, Yuen CH, et al. Significance of HBV DNAlevels in liver histology of HBeAg and Aiti HBe positive patients with chronic hepatitis B. Am J Gastroenterol 2004;99:2032-7.
40. Manesis EK Papatheodoridis GV Sevastianos V Cholongitas E, Papaioannou C, Hadziyannis SJ. Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with HBeAg-negative chronic hepatitis B virus infection. An J Gastroenterol 2003;98:2261-7.
41. Fattovich Q Brollo I, Alberti A Pontisso P, Giustina G, Realdi G. Long term follow-up of anti-HBe positive chronic active hepatitis B Hepatology 1988;8:1651-4.
42. McMahon BJ. The natural history of chronic hepatitis B virus infection. Semin Liver Dis 2004;24:17-21
43. Xu B, Hu DC, Rosenberg DM, Jiang QW, Lin XM, Lu JL, et al. Chronic hepatitis B: Along-term retrospective cohort; study of disease progression in Shanghai, China. J Gastroenterol Hepatol 2003;18:1345-52.
44. Wu GC, Zhou WP, Zhao YR, Quo SH, Wang ZY, Zou SB, et al. The natural history of chronic hepatitis B A retrospective study. Hepatobiliary Pancreat Dis Int 2003;2:566-70.
45. Marx G, Martin SR, Chicoine JF, Avarez E Long-term follow up of chronic hepatitis B virus infections in children of different ethnic origins. J Infect Dis 2002;186:295-301.